Table 4 Dose titration strategy and compliance with study medications
Dose titration strategy: Participants who remained in the study until their final study assessment (i.e. excluding withdrawals), n = 40 | Usual TSH range (0.4–4.0 mU/L) n = 21 | Higher TSH range (4. 1–8.0 mU/L) n = 19 |
|---|---|---|
Percent achieving target TSH range at week 12 (visit 2) | 18/21 (85.7 %) | 6/19 (31.6 %) |
Percent achieving target TSH range at week 24 (visit 3) | 18/21 (85.7 %) | 10/19 (52.6 %) |
Percent compliant at week 12 (visit 2) | 21/21 (100 %) | 18/19 (94.7 %) |
Percent compliant at week 24 (visit 3) | 21/21 (100 %) | 18/19 (94.7 %) |